This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Fujirebio Inc., Rebio Gen, Inc.. Active years: 2006-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kanagawa, JP (2006)
- Yokohama, JP (2008)
Company Filing History:
Years Active: 2006-2008
Title: Motowo Tomita: Innovator in Diabetes Diagnosis and Monitoring
Introduction
Motowo Tomita is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the area of diabetes. With a total of 2 patents, his work focuses on innovative methods for diagnosing and monitoring diabetes and related metabolic disorders.
Latest Patents
Tomita's latest patents include a method for diagnosing type II diabetes and monitoring the therapeutic effects of agents for this condition. This invention provides a means to diagnose geriatric diseases associated with insulin resistance, such as type II diabetes, at an early stage. It also offers a method for monitoring the therapeutic effects of agents for type II diabetes by quantitatively assaying GBP28 using a monoclonal antibody that can assay adiponectin (GBP28) in a sample. Another significant patent involves a method for diagnosing or monitoring carbohydrate metabolism disorders, which similarly addresses early diagnosis and monitoring of therapeutic effects related to insulin resistance.
Career Highlights
Throughout his career, Tomita has worked with reputable companies such as Rebio Gen, Inc. and Fujirebio Inc. His experience in these organizations has contributed to his expertise in medical diagnostics and innovation.
Collaborations
Some of his notable coworkers include Yasuko Nakano and Hiroshi Hirose. Their collaboration has likely played a role in advancing the research and development of diagnostic methods in the field of diabetes.
Conclusion
Motowo Tomita's contributions to diabetes diagnosis and monitoring highlight his innovative spirit and dedication to improving healthcare. His patents reflect a commitment to addressing critical health issues associated with insulin resistance.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
